Nuplex’s purchase of the Med-Chem product range is expected to lift the earnings of the resin manufacturer’s specialties business by 15% a year.

The company is keeping quiet on the price of the acquisition but it includes the total goodwill of the Australian and New Zealand ingredient business of the Med-Chem group of companies.

Med-Chem’s other assets will remain with the current owner when the formal handover is made on Friday.